Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial.
Journal article
Williams LR. et al, (2024), Vaccine
Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study.
Journal article
Dyson ZA. et al, (2024), Lancet Microbe
Improved estimates of COVID-19 correlates of protection, antibody decay and vaccine efficacy waning: a joint modelling approach
Preprint
Phillips DJ. et al, (2024)
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.
Journal article
Feng S. et al, (2024), Health Technol Assess, 28, 1 - 109
Inflammation of the Nasal Mucosa is Associated with Susceptibility to Experimental Pneumococcal Challenge in Older Adults.
Journal article
Urban BC. et al, (2024), Mucosal Immunol
Towards paratyphoid control: the vital role of the challenge model
Journal article
McCann N. et al, (2024), The Lancet, 403, 2780 - 2781
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.
Journal article
Costa Clemens SA. et al, (2024), Lancet Microbe
Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study.
Journal article
Kandasamy R. et al, (2024), Vaccine
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Journal article
Maytum A. et al, (2024), Pediatr Infect Dis J
A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial
Journal article
Dinh Thiem V. et al, (2024), Vaccine
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.
Journal article
Iwata S. et al, (2024), Sci Rep, 14
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
Journal article
Jackson S. et al, (2024), Lancet Microbe
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.
Journal article
Drury RE. et al, (2024), Nat Commun, 15
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
Journal article
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators None., (2024), Lancet Infect Dis
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine.
Journal article
Cotugno N. et al, (2024), JCI Insight, 9
Evaluating the Impact of the BioFire FilmArray in Childhood Meningitis: An Observational Cohort Study.
Journal article
Kadambari S. et al, (2024), Pediatr Infect Dis J, 43, 345 - 349
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
Journal article
Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53
Typhoid conjugate vaccines: a step towards typhoid control.
Journal article
Shakya M. and Pollard AJ., (2024), Lancet Glob Health, 12, e535 - e536
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.
Journal article
Martin NG. et al, (2024), J Infect, 88
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age.
Journal article
Bijukchhe SM. et al, (2024), Vaccine, 42, 2018 - 2025